Employer Connect – BiotechReality – Information Intelligence System for Biopharma

Eli Lilly and Company (NYSE: LLY) has officially announced the launch of Lilly Employer Connect, a groundbreaking platform designed to bridge the significant access gap in U.S. obesity care. By partnering with over fifteen independent program administrators, Lilly aims to provide employers with flexible, transparent, and affordable pathways to provide chronic weight management treatments for their workforce. Addressing the Obesity Crisis and Coverage Gap Obesity currently affects more than 100 million adults in the United States, placing a staggering $1.7 trillion annual burden on the economy through direct medical costs and lost productivity. Despite its classification as a chronic disease, insurance coverage remains inconsistent. Currently, approximately half of all commercially insured employees in the U.S. lack covered access to essential obesity management medications. Strategic Partnerships and Transparent Pricing The platform's strength lies in its diverse network of independent program administrators and pharmacy partners. These include organizations such as Mark Cuban Cost Plus Drug Company, 9amHealth, Calibrate Health, and HealthDyne, among others. This structure allows employers to tailor their benefits programs to their specific budget and workforce needs, whether they require low-cost administration or comprehensive, "wraparound" support services like virtual clinical care and behavioral coaching. Read More: Eli Lilly Cuts Zepbound Prices for Self-Pay Patients Following White House Deal As part of the launch, Lilly is offering Zepbound® (tirzepatide) KwikPen® to network pharmacies at a discounted price of $449 for all doses. While the final cost to the employer and employee may vary based on the specific program administrator and cost-sharing model chosen, this initiative provides a clear and predictable baseline for weight management expenses. Scaling Access Through Innovation Lilly Employer Connect is designed to evolve. The company plans to continuously expand its list of program administrators, which already features notable names such as: 9amHealth Mark Cuban Cost Plus Drug Company GoodRx Calibrate Health eMed Form Health ReviveHealth By decoupling obesity care from traditional, often restrictive benefit designs, Lilly is empowering employers to prioritize long-term employee health and productivity through sustainable, evidence-based medical interventions. Eli Lilly and Company

Tag: Employer Connect

Lilly Launches “Employer Connect” to Revolutionize Obesity Care Access

Areas Covered

Discover More

Novartis Immunology Data at AAD 2026: Rhapsido and Cosentyx Results

GSK Secures Japan Orphan Drug Designation for Risvutatug Rezetecan in Small-Cell Lung Cancer

Pfizer’s Talzenna + Xtandi Delivers Proven rPFS Breakthrough in HRR-Mutated mCSPC

Eli Lilly Declares Powerful 2% A1C Reduction and 17% Weight Loss in Landmark Phase 3 Trial Results of Retatrutide

ICOTYDE FDA Approval: J&J’s First-Line Oral Peptide Breakthrough for Plaque Psoriasis Treatment

Atirmociclib Phase 2 Breakthrough: Pfizer Declares Powerful Results for Metastatic Breast Cancer Treatment